外科理论与实践

外科理论与实践 >

2026 , Vol. 31 >Issue 01: 50 - 57

DOI: https://doi.org/10.16139/j.1007-9610.2026.01.09

论著

单气囊小肠镜辅助内镜逆行胰管造影治疗胰肠吻合口狭窄的临床应用

  • 周学平 ,
  • 翁昊 ,
  • 翁明哲 ,
  • 束翌俊 ,
  • 赵铭宁 ,
  • 顾钧 ,
  • 王雪峰
展开
  • 上海交通大学医学院附属新华医院普外科， 上海市胆道疾病重点实验室， 上海 200092
第一联系人：

*：共同第一作者

周学平负责研究设计、数据分析和撰写；翁昊、翁明哲负责数据收集，束翌俊、赵铭宁负责审校、提供意见；顾钧负责数据核对；王雪峰负责指导研究设计并审查和修订文章。

王雪峰，E-mail：wxxfd@live.cn

收稿日期: 2025-05-31

  网络出版日期: 2026-04-21

收起

Application of single balloon enteroscopy-assisted endoscopic retrograde pancreatography in patients with pancreaticojejunal anastomotic stenosis

  • ZHOU Xueping ,
  • WENG Hao ,
  • WENG Mingzhe ,
  • SHU Yijun ,
  • ZHAO Mingning ,
  • GU Jun ,
  • WANG Xuefeng
Expand
  • Department of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China

Received date: 2025-05-31

  Online published: 2026-04-21

Fold

摘要

目的：评估胰肠吻合口狭窄(PJS)病人单气囊小肠镜（SBE）辅助内镜逆行胰管造影（ERP）的可行性、有效性和远期疗效。方法：回顾性分析2016年3月至2021年3月接受SBE辅助ERP的16例PJS病例，评估技术操作成功、不良事件、失败风险因素和长期随访结果。结果：16例中8例治疗成功，成功率为50%，ERP后无严重并发症发生，胰空肠吻合部位辨认失败的危险因素包括消化道Child重建(P=0.001)、胰空肠黏膜对黏膜吻合(P=0.001)、术中未放置胰管支架(P=0.037)、术前胰管不扩张(P=0.037)和术后胰瘘(P=0.001)。此外，吻合口辨认成功组胰十二指肠切除(PD)术后首次出现腹痛间隔时间明显长于失败组（44.7个月比19.9个月，P=0.044），而出现症状至首次ERP干预时间短于失败组（8.4个月比22.4个月，P=0.021）。随访期间[77.2（6.8，187.7）个月]，复发率为25%，7例内镜胰管引流术治疗病人的支架置入总时间为62.3（6.8，153.7）个月，ERP治疗成功后未复发病人的体质量指数（BMI）变化均值为+2.46 kg/m2，而复发病人为-1.09 kg/m2，ERP治疗失败病人为-2.12 kg/m2。结论：PD后PJS的SBE辅助ERP治疗显示出良好的安全性、有效性和持久的疗效。一旦发生PJS，应及早进行ERP干预并放置胰管支架，以减少吻合口狭窄的复发。BMI是随访的重要监测指标。

关键词： 胰十二指肠切除术; 胰肠吻合口狭窄; 内镜逆行胰管造影; 单气囊小肠镜

本文引用格式

周学平 , 翁昊 , 翁明哲 , 束翌俊 , 赵铭宁 , 顾钧 , 王雪峰 . 单气囊小肠镜辅助内镜逆行胰管造影治疗胰肠吻合口狭窄的临床应用[J]. 外科理论与实践, 2026 , 31(01) : 50 -57 . DOI: 10.16139/j.1007-9610.2026.01.09

Abstract

Objective To evaluate the feasibility, effectiveness, and long-term outcome of single balloon enteroscopy(SBE)-assisted endoscopic retrograde pancreatography(ERP) in patients with pancreaticojejunal anastomotic stenosis (PJS). Methods The clinical data of 16 PJS cases undergoing SBE-assisted ERP from March 2016 to March 2021 were retrospectively reviewed. Technical and clinical success, adverse events, risk factors for failure and long-term outcomes were assessed. Results Eight of 16 patients were successfully treated, the success rate was 50%. No serious complications after ERP occurred. Risk factors for failure of pancreaticojejunostomy site identification included digestive tract Child reconstruction sequence (P=0.001), pancreaticojejunostomy method (P=0.001), without pancreatic duct support tube placement (P=0.037), undilated preoperative pancreatic duct (P=0.037) and postoperative pancreatic fistula (P=0.001). The interval between the first occurrence of abdominal pain after pancreaticoduodenectomy (PD) operation in the successful anastomotic site identification group was significantly longer than that in the failed group（44.7 months vs. 19.9 months, P=0.044）, while the time from symptom onset to the first ERP intervention was shorter than that in the anastomotic site identification failed group （8.4 months vs. 22.4 months, P=0.021）. During the follow-up periods [77.2(6.8, 187.7)months], recurrence rates were 25%. The total duration of stent placement in 7 patients with endoscopic pancreatic drainage treatment was 62.3 (6.8, 153.7). Body mass index (BMI) variation is +2.46 kg/m2 in non-recurrence group compare to -1.09 kg/m2 in recurrence group and -2.12 kg/m2 in ERP treatment failure group. Conclusions SBE-assisted ERP treatment for PJS after PD showed favorable safety, effectiveness and durable long-term outcomes. ERP intervention should be carried out early once PJS occurs. BMI is an important index to be monitored during the follow-up of PJS patients.

Key words： Pancreaticoduodenectomy (PD); Pancreaticojejunostomy anastomotic stenosis (PJS); Endoscopic retrograde pancreatography (ERP); Single balloon enteroscopy (SBE)

参考文献

[1] WOLFGANG C L, PAWLIK T M. Pancreaticoduodenectomy: time to change our approach?[J]. Lancet Oncol, 2013, 14(7):573-575.
[2] NASSOUR I, CHOTI M A. Pancreatic operations[J]. JAMA, 2016, 316(18):1932.
[3] REGIMBEAU J M, REBIBO L, DOKMAK S, et al. The short- and long-term outcomes of pancreaticoduodenectomy for cancer in Child A patients are acceptable: a patient-control study from the Surgical French Association report for pancreatic surgery[J]. J Surg Oncol, 2015, 111(6):776-783.
[4] ZARZAVADJIAN LE BIAN A, CESARETTI M, TABCHOURI N, et al. Late pancreatic anastomosis stricture following pancreaticoduodenectomy: a systematic review[J]. J Gastrointest Surg, 2018, 22(11):2021-2028.
[5] DEMIRJIAN A N, KENT T S, CALLERY M P, et al. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures[J]. HPB (Oxford), 2010, 12(7):482-487.
[6] KIDA A, SHIROTA Y, HOUDO Y, et al. Endoscopic characteristics and usefulness of endoscopic dilatation of anastomotic stricture following pancreaticojejunostomy: case series and a review of the literature[J]. Therap Adv Gastroenterol, 2016, 9(6):913-919.
[7] KOGURE H, SATO T, NAKAI Y, et al. Endoscopic management of pancreatic diseases in patients with surgically altered anatomy: clinical outcomes of combination of double-balloon endoscopy- and endoscopic ultrasound-guided interventions[J]. Dig Endosc, 2021, 33(3):441-450.
[8] KIDA A, SHIROTA Y, KAWANE T, et al. Long-term outcomes after endoscopic retrograde pancreatic drainage for symptomatic pancreaticojejunal anastomotic stenosis[J]. Sci Rep, 2021, 11(1):4489.
[9] COTTON P B, LEHMAN G, VENNES J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus[J]. Gastrointest Endosc, 1991, 37(3):383-393.
[10] COTTON P B, EISEN G M, AABAKKEN L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop[J]. Gastrointest Endosc, 2010, 71(3):446-454.
[11] M?NKEMüLLER K, FRY L C, BELLUTTI M, et al. ERCP with the double balloon enteroscope in patients with Roux-en-Y anastomosis[J]. Surg Endosc, 2009, 23(9):1961-1967.
[12] ITOI T, ISHII K, SOFUNI A, et al. Single-balloon entero-scopy-assisted ERCP in patients with Billroth Ⅱ gastrectomy or Roux-en-Y anastomosis (with video)[J]. Am J Gastroenterol, 2010, 105(1):93-99.
[13] SIDDIQUI A A, CHAAYA A, SHELTON C, et al. Utility of the short double-balloon enteroscope to perform pancreaticobiliary interventions in patients with surgically altered anatomy in a US multicenter study[J]. Dig Dis Sci, 2013, 58(3):858-864.
[14] KATANUMA A, YANE K, OSANAI M, et al. Endoscopic retrograde cholangiopancreatography in patients with surgically altered anatomy using balloon-assisted enteroscope[J]. Clin J Gastroenterol, 2014, 7(4):283-289.
[15] MENON K V, SANAKA M. Successful single-balloon enteroscopic dilation of late anastomotic pancreaticojejunostomy stricture following whipple procedure[J]. Pancreas, 2010, 39(1):115-116.
[16] KIKUYAMA M, ITOI T, OTA Y, et al. Therapeutic endoscopy for stenotic pancreatodigestive tract anastomosis after pancreatoduodenectomy (with videos)[J]. Gastrointest Endosc, 2011, 73(2):376-382.
[17] PARK J H, YE B D, BYEON J S, et al. Approaching pancreatic duct through pancreaticojejunostomy site with double ballon enteroscope in patients with Roux-en-Y anatomy[J]. Hepatogastroenterology, 2013, 60(127):1753-1758.
[18] SHIMATANI M, MATSUSHITA M, TAKAOKA M, et al. Effective "short" double-balloon enteroscope for diagnostic and therapeutic ERCP in patients with altered gastrointestinal anatomy: a large case series[J]. Endoscopy, 2009, 41(10):849-854.
[19] FARRELL J, CARR-LOCKE D, GARRIDO T, et al. Endoscopic retrograde cholangiopancreatography after pancreaticoduodenectomy for benign and malignant disease: indications and technical outcomes[J]. Endoscopy, 2006, 38(12):1246-1249.
[20] CIOFFI J L, MCDUFFIE L A, ROCH A M, et al. Pancreaticojejunostomy stricture after pancreatoduodenectomy: outcomes after operative revision[J]. J Gastrointest Surg, 2016, 20(2):293-299.
[21] ELMUNZER B J, PIRAKA C R. EUS-guided methylene blue injection to facilitate pancreatic duct access after unsuccessful ERCP[J]. Gastroenterology, 2016, 151(5):809-810.
[22] WIDMER J, SHARAIHA R Z, KAHALEH M. Endoscopic ultrasonography-guided drainage of the pancreatic duct[J]. Gastrointest Endosc Clin N Am, 2013, 23(4):847-861.
[23] ERGUN M, AOUATTAH T, GILLAIN C, et al. Endoscopic ultrasound-guided transluminal drainage of pancreatic duct obstruction: long-term outcome[J]. Endoscopy, 2011, 43(6):518-525.
[24] HODO Y, SHIROTA Y, SUDA T, et al. Successful EUS-guided retrograde pancreatic duct stent placement for refractory pancreaticojejunostomy stricture after pancreaticoduodenectomy with a forward-viewing echoendoscope[J]. VideoGIE, 2018, 3(6):196-198.
[25] MOREELS T G. Endoscopic retrograde cholangiopancreatography in patients with altered anatomy: how to deal with the challenges?[J]. World J Gastrointest Endosc, 2014, 6(8):345-351.
[26] TAKIKAWA T, KANNO A, MASAMUNE A, et al. Pancreatic duct drainage using EUS-guided rendezvous technique for stenotic pancreaticojejunostomy[J]. World J Gastroenterol, 2013, 19(31):5182-5186.
[27] SANO I, KATANUMA A, KUWATANI M, et al. Long-term outcomes after therapeutic endoscopic retrograde cholangiopancreatography using balloon-assisted enteroscopy for anastomotic stenosis of choledochojejunostomy/pancreaticojejunostomy[J]. J Gastroenterol Hepatol, 2019, 34(3):612-619.
[28] MATSUBAYASHI H, KISHIDA Y, SHINJO K, et al. Endoscopic ultrasound-guided retrograde pancreatic stent placement for the treatment of stenotic jejunopancreatic anastomosis after a Whipple procedure[J]. Endoscopy, 2013, 45(Suppl 2 UCTN):E435-E436.
[29] MORGAN D E, SMITH J K, HAWKINS K, et al. Endoscopic stent therapy in advanced chronic pancreatitis: relationships between ductal changes, clinical response, and stent patency[J]. Am J Gastroenterol, 2003, 98(4):821-826.
[30] SMITS M E, BADIGA S M, RAUWS E A, et al. Long-term results of pancreatic stents in chronic pancreatitis[J]. Gastrointest Endosc, 1995, 42(5):461-467.
Options
文章导航

/

〈 〉